M A K E
IT
H A P P E N
Codexis
continues to expand
the frontiers of the possible in bio-based science
Pfizoi's challenge was to reduce the formation of a closely related by-product in the fermentative production of Doramectin More by-product than product was generated by the manufacturing organism, reguiring costly separations Using our proprietary MolecularBreeding ' technologies to improve a selectivity-controlling gene, we not only reduced the by-product formation to low levels, but also increased the fermentation yield of Doramectin. The improved organism is now being used in commercial manufacture, providing considerable manufacturing savings.
This is just one of the many challenging process improvements where our truly revolutionary technology is delivering for our life science partners.
If you want creative, innovative bio-based solutions for your pharmaceutical, make it happen with Codexis.
CODEXIS
w w w . c o d e x i s . c o m Call: US West Coast : 650 298 5329 US East Coast : 610-648-3995 Europe : 4 44(0)1865 823182
